✦ LIBER ✦

Dynamics of CXC group chemokine platelet factor 4 (PF4) plasma levels in non-small cell lung cancer (NSCLC)

✍ Scribed by Artjoms Spaks, Inta Jaunalksne, Simona Donina…

Book ID: 120690286
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 70 KB
Volume: 10
Category: Article
ISSN: 1479-5876
DOI: 10.1186/1479-5876-10-S3-P9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

35 ROLE OF CXCL4 CHEMOKINE IN ANGIOGENIC

35 ROLE OF CXCL4 CHEMOKINE IN ANGIOGENIC ACTIVITY OF NON-SMALL CELL LUNG CANCER (NSCLC)

✍ Spaks, A.; Isajeva, D.; Spaka, I.; Pirtnieks, A.; Jaunalksne, I.; Grusina-Ujumaz 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Expression of Cancer Stem Cell Transcrip

Expression of Cancer Stem Cell Transcription Factor SALL4 in Non-small Cell Lung Carcinomas (NSCLC)

✍ Rodriguez, Erika; Geddes, Susan; Gabrielson, Edward; Askin, Frederic; Li, Qing K 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 84 KB

1446 POSTER Evaluation of CTL Antigen 4

1446 POSTER Evaluation of CTL Antigen 4 (CTLA-4) Expression as Prognostic Factor in Non-small Cell Lung Cancer (NSCLC)

✍ F. Grossi; E. Rijavec; G. Barletta; C. Genova; M.G. Dal Bello; S. Salvi; D.F. Me 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Prognostic value of plasma carcinoembryo

Prognostic value of plasma carcinoembryonic antigen (CEA) and tissue polipeptide antigen (TPA) levels in non small cell lung cancer (NSCLC)

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Reaction of plasma hepatocyte growth fac

Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIs

✍ Hidenori Tanaka; Tatsuo Kimura; Shinzoh Kudoh; Shigeki Mitsuoka; Tetsuya Watanab 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 242 KB

## Abstract Hepatocyte growth factor induces resistance to epidermal growth factor receptor tyrosine kinase inhibitors. It has been hypothesized that epidermal growth factor receptor tyrosine kinase inhibitors administration may influence the levels of plasma hepatocyte growth factor. Patients with

6593 POSTER Nerve growth factor (NGF) le

6593 POSTER Nerve growth factor (NGF) levels in plasma in patients with advanced non-small cell lung cancer patients (NSCLC). Is it predictive of clinical outcome?

✍ Sirera, R.; Camps, C.; Caballero, C.; Safont, M.J.; Blasco, A.; Gavila, J.; Cabr 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB